REMNOCT Trademark

Trademark Overview

On Wednesday, February 16, 2011, a trademark application was filed for REMNOCT with the United States Patent and Trademark Office. The USPTO has given the REMNOCT trademark a serial number of 85244306. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, July 3, 2014. This trademark is owned by Allergan, Inc.. The REMNOCT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of nocturia
remnoct

General Information

Serial Number85244306
Word MarkREMNOCT
Filing DateWednesday, February 16, 2011
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, July 3, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of nocturia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, July 3, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSERENITY PHARMACEUTICALS LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMILFORD, PA 18337
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92604
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92604

Trademark Events

Event DateEvent Description
Wednesday, July 5, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 28, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 28, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 3, 2014ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, July 3, 2014ABANDONMENT - AFTER PUBLICATION
Wednesday, July 2, 2014TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, January 11, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2014EXTENSION 5 GRANTED
Thursday, January 9, 2014EXTENSION 5 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Thursday, June 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2013EXTENSION 4 GRANTED
Tuesday, May 21, 2013EXTENSION 4 FILED
Tuesday, June 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 21, 2013TEAS EXTENSION RECEIVED
Tuesday, January 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2013EXTENSION 3 GRANTED
Wednesday, January 9, 2013EXTENSION 3 FILED
Wednesday, January 9, 2013TEAS EXTENSION RECEIVED
Tuesday, July 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2012EXTENSION 2 GRANTED
Tuesday, July 17, 2012EXTENSION 2 FILED
Friday, July 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Friday, January 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2012EXTENSION 1 GRANTED
Wednesday, January 11, 2012EXTENSION 1 FILED
Wednesday, January 11, 2012TEAS EXTENSION RECEIVED
Tuesday, August 23, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Tuesday, May 17, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2011ASSIGNED TO EXAMINER
Tuesday, February 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 19, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

remnoct nocturia treatment preparations pharmaceutical